2. Signaling Pathways
  3. MAPK/ERK Pathway
  4. p38 MAPK
  5. p38 MAPK Antagonist

p38 MAPK Antagonist

p38 MAPK Isoform Comparison

p38 MAPK Antagonist (1):

Cat. No. Product Name Effect Purity
  • HY-124615
    ST-162
    		Antagonist
    ST-162 is a MAPK/PI3K dual antagonist. ST-162 exhibits antitumor activity and can increase the efficacy of immune checkpoint blockers. ST-162 can be used for the research of cancer, such as melanoma.